search.noResults

search.searching

note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
PAUL EDWARDS – VICE PRESIDENT MEDICAL GASES, AIR LIQUIDE HEALTHCARE MEDICAL GASES


Assessing the quality of on site medical air


A number of standards include system design guidance to help acute care facilities achieve a reliable supply of medical air, but they do not look at how to measure and ensure product quality. However, healthcare facilities producing medical air must now conduct a quality risk assessment and where necessary, continuously monitor quality.


In North America and Europe, most acute care facilities produce medical air on site. It’s a simple process and much cheaper than using commercially produced high-pressure cylinders. Canadian Standards Association (CSA), National Fire Protection Association (NFPA), International Organization for Standardization (ISO) and Health Technical Memoranda (HTM) standards all offer system design guidance to achieve supply reliability, and in north America the prevailing CSA and NFPA standards prescribe a baseline product quality equivalent to the United States Pharmacopeia (USP) specification for medical air. However, it is the last point that the


standards do not address. They prescribe quality but remain silent on how to measure and ensure product quality. With the objective of filling this gap, since launching the aerALin quality control service in 2014, Air Liquide Healthcare has routinely notified the CSA of measured quality incidents. As a result, in the 2017 edition of Canada’s medical gas pipeline systems standard Z7396.1, there is a new requirement for healthcare facilities producing medical air; they must now conduct a quality risk assessment and where deemed in the best interests of patient safety, employ continuous quality monitoring with the means to prevent off- spec product from entering the pipeline. So how does one go about assessing


product quality risk? The most common approach starts with three questions: l What can go wrong? l What is the likelihood that something will go wrong?


l What is the severity or impact, should something go wrong?


Answering the first question can be as simple as looking outdoors. On site medical air quality is linked to outdoor air quality. Smoke from a forest fire, a vehicle exhaust, a power generator or industry near and far may influence the air


84


On site medical air quality is linked to outdoor air quality.


drawn in by medical air compressors. While standard medical air filtration does a reasonable job of blocking fine particles, it does little to filter chemical impurities. Therefore, the answer to the first question is, a whole host of things that are outside the control of the producer. So, what is the likelihood that product quality will drift out of bounds? Through a quality control service, the authors have amassed over 60 million data points that show:


l quality breaches occur without warning, day and night


l most breaches last less than 10 minutes, while some persist for days


l the most common breach is CO2 > 500 ppm


l root causes range from production methodology to variable outdoor air quality


l quality breaches have occurred at every site they monitor, rural and urban.


Paul Edwards


Paul Edwards, vice president medical gases, Air Liquide Healthcare, has been actively involved in the medical gas industry since 1991. He is a long standing member of the CSA Z251.20 technical sub-committee responsible for medical gas standards and is an active member and strong supporter of CHES. Paul is recognised as a pioneer in quality


control for gaseous drugs produced on site. He has championed the cause through lectures across Canada, the US and Europe, and has been published in the Canadian Healthcare Facilities Guide and the 2016 IFHE Digest.


IFHE DIGEST 2018


©Jean-Paul Bounine/Fotolia


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88